Lytix Biopharma AS Navne-Aksjer NK -,10

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

7.65%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.07 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.808 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 09:57:12 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.8180.772
PREV. DAY'S PRICE0.816 (07/22)
CHANGE DAY BEFORE
-0.01
-0.98 %
52 WEEK HIGH / LOW1.055 (04/10)0.524 (09/26)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.19-0.15-0.07-0.06-0.12
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
3.793.7110.92--
PRICE - SALES RATIO
48.7928.58---
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A3CSAK
ISIN
NO0010405780
SYMBOL
6BG
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
LYTIX BIOPHARMA NK -,10
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-1.21 %
0.74 %
-7.90 %
8.22 %
7.65 %
31.61 %
-31.31 %
4.88 %
HIGH0.830.881.041.061.061.151.501.06
LOW0.770.710.680.680.520.310.310.68

Dividende

pro Aktie
LYTIX BIOPHARMA NK -,10 does not deliver dividend information

Company profile

Lytix Biopharma ASA engages in the development of novel drugs for the treatment of resistant bacterial and fungal infections, as well as oncology treatments. The company was founded by Øystein Rekdal and John Sigurd Mjøen Svendsen in 2003 and is headquartered in Tromso, Norway.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.